http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
-
22nd Century Group (XXII) Issues Annual Letter to Shareholders
-
22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
-
22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
-
22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
-
22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
-
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
-
First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland
-
First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland
-
22nd Century Group (XXII) Appoints Calvin Treat as Chief Scientific Officer
-
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
-
22nd Century Group (XXII) Announces Reduced-Nicotine Cigarette That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
-
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
-
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
-
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021
-
22nd Century Group (XXII) Announces South Korea as First VLN International Market
-
22nd Century Group Announces South Korea as First VLN® International Market
-
22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes
-
22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation
-
22nd Century Group (XXII) Secures USDA Organic Certification for Needle Rock Farms
-
22nd Century Secures USDA Organic Certification for Needle Rock Farms
-
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
-
22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes
-
22nd Century Group (XXII) Announces First Production of VLN® Cigarettes for Retail Sale
-
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
-
22nd Century Group (XXII) Appoints James A. Mish to Its Board
-
22nd Century Group Appoints James A. Mish to Its Board of Directors
-
22nd Century Group (XXII) Says it's Launching First Reduced Nicotine Cigarette Authorized by FDA That Helps You Smoke Less
-
22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
-
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
-
22nd Century Group (XXII) Granted FDA Approval for VLN as a Modified Risk Tobacco Product
-
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
-
22nd Century Group (XXII) Confirms FDA Authorizes Marketing of its VLN as Modified Risk Tobacco Product
-
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
-
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
-
22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes
-
22nd Century Group (XXII) Announces CFO Transition
-
22nd Century Group Announces CFO Transition
-
22nd Century Group Applauds Califf Nomination as FDA Commissioner
-
22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021
-
22nd Century Group Reports Business Highlights and Financial Results for the Third Quarter 2021
-
22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results
-
22nd Century Group VP of Regulatory Science to Participate in FDLI Panel in Response to Recent FDA Action on Comprehensive Plan and Reduced Nicotine Mandate
-
22nd Century to Participate in the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7
-
22nd Century to Participate in September and October 2021 Investor Conferences
-
22nd Century Group Enters Global Specialty Hops Market
-
22nd Century Group (XXII) Appoints Anthony Johnson to its Board
-
22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors
-
22nd Century to Present at SNN Network Investor Conference on August 19
-
22nd Century Group to Ring Nasdaq Closing Bell Today, August 16
